Establishing secure connection…Loading editor…Preparing document…

Legal CIIAA Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Legal CIIAA Document

This Confidential Information, Inventions and Assignment Agreement (the Agreement) is entered into as of Date: by and between Company Name: , a Corporation LLC Individual, with principal place of business at (Company), and Individual Name: , residing at (Participant).

RECITALS

WHEREAS, the Company develops and maintains confidential business information, trade secrets, inventions and other proprietary materials that provide a competitive advantage and represent substantial investment by the Company; and

WHEREAS, the Participant will have access to and may create or develop certain confidential information and inventions in the course of performing services for the Company; and

WHEREAS, the Company requires, as a condition of participation, that the Participant acknowledge the confidential nature of such information and assign to the Company certain rights in inventions and improvements made by the Participant relating to the Company's business.

NOW, THEREFORE, in consideration of the mutual covenants and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. DEFINITIONS

1.1 Confidential Information means any non-public information disclosed by the Company or learned by the Participant, whether or not marked confidential, concerning the Company's business, products, services, processes, technical data, software, know-how, trade secrets, customer lists, pricing, marketing plans, financial information, or other proprietary information, in any form or medium.

2. CONFIDENTIALITY OBLIGATIONS

2.1 Nonuse and Nondisclosure. The Participant shall hold Confidential Information in strict confidence, shall not use such information except to perform services for the Company, and shall not disclose Confidential Information to any third party without the Company's prior written consent. The Participant shall apply at least the same degree of care to protect the Confidential Information as the Participant applies to its own most sensitive information, but in no event less than reasonable care.

2.2 Permitted Disclosure. The obligations in Section 2.1 do not apply to information that: (a) is or becomes generally available to the public through no fault of the Participant; (b) was rightfully in the Participant's possession without restriction prior to receipt from the Company as evidenced by written records; (c) is rightfully disclosed to the Participant by a third party without restriction; or (d) is independently developed by the Participant without use of or reference to the Company's Confidential Information.

3. INVENTIONS; ASSIGNMENT

3.1 Inventions Defined. "Inventions" means all discoveries, ideas, improvements, developments, processes, formulas, designs, works of authorship, software (including object code and source code), techniques, know-how, algorithms, mask works and other intellectual property, whether or not patentable or registrable, that the Participant conceives, develops or reduces to practice, alone or jointly, during the term of the Participant's engagement with the Company and that (a) relate to the Company's current or demonstrably anticipated business, research, or development, or (b) result from work performed for the Company.

3.2 Assignment. To the maximum extent permitted by applicable law, the Participant hereby assigns and agrees to assign to the Company all right, title and interest in and to all Inventions. The Participant will promptly disclose to the Company all Inventions and execute all documents and take all actions reasonably requested by the Company to record, protect, perfect and enforce the Company's rights in such Inventions, including without limitation assignments, patent applications, and other filings.

3.3 Prior Inventions. The Participant certifies that the information set forth below identifies all inventions, designs, works of authorship or other intellectual property that the Participant conceived or reduced to practice prior to the effective date and that the Participant contends are excluded from this Agreement. If none, indicate "None."

4. ASSISTANCE AND FURTHER ACTIONS

The Participant shall, during and after the term of engagement, execute documents and take such steps as the Company may reasonably request to assist the Company in obtaining, perfecting, enforcing and transferring any intellectual property rights in the Inventions, including cooperation with patent prosecution and litigation. If the Company is unable for any reason to secure Participant's signature on any document necessary to effectuate such assignment, Participant hereby irrevocably designates and appoints the Company as Participant's agent and attorney-in-fact to execute and file any such document.

5. RETURN OF MATERIALS

Upon termination of the Participant's engagement or upon the Company's request, the Participant shall promptly return all materials and embodiments of Confidential Information and Inventions in the Participant's possession, including electronic copies, and shall not retain any copies thereof.

6. REMEDIES

The Participant acknowledges that breach of this Agreement will cause irreparable harm to the Company for which monetary damages would be inadequate. Accordingly, the Company shall be entitled, in addition to any other remedies available at law or in equity, to seek injunctive or other equitable relief to enforce this Agreement without the requirement to post bond.

7. TERM; SURVIVAL

This Agreement shall commence on the effective date set forth above and shall survive termination of the Participant's engagement to the extent necessary to effectuate the obligations herein. Sections relating to Confidentiality, Assignment, Remedies and Miscellaneous provisions shall survive termination.

8. MISCELLANEOUS

8.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the state of , without regard to its conflict of laws principles.

8.2 Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written.

8.3 Severability. If any provision of this Agreement is found to be invalid or unenforceable, the remainder of this Agreement shall remain in full force and effect and such provision shall be reformed only to the extent necessary to make it enforceable.

8.4 Amendments; Waiver. No amendment or waiver of any provision of this Agreement shall be effective unless in writing and signed by both parties. The failure to enforce any provision shall not constitute a waiver of that or any other provision.

8.5 Notices. All notices under this Agreement shall be in writing and delivered by hand, overnight courier or certified mail, return receipt requested, to the addresses set forth below or to such other address as a party may designate in writing. Notices shall be deemed given upon receipt.

8.6 Counterparts; Electronic Signatures. This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. Electronic or facsimile signatures shall be binding as original signatures.

ACKNOWLEDGMENT

The Participant acknowledges that the Participant has read and understands this Agreement, that the Participant has had the opportunity to seek independent legal advice, and that the obligations herein are reasonable in scope and necessary to protect the Company's legitimate business interests.

Company

Printed Name:

By:

Date:

Participant

Printed Name:

By:

Date:

Enter text✕

What the Legal CIIAA Document Is and when it applies

The Legal CIIAA Document is a contractual form used to define confidentiality obligations and assign intellectual property rights between parties in a commercial or employment context. It typically identifies the parties, describes confidential information, sets use and disclosure restrictions, contains assignment of inventions or work product clauses, and specifies term, governing law, and remedies. The document can be executed in paper or electronically where permitted by federal and state law; ensuring correct signer authority, clear dates, and accurate party identification are essential for enforceability.

Why a properly drafted Legal CIIAA Document matters

A clear Legal CIIAA Document allocates rights and limits risk by defining confidential materials, preserving ownership of inventions, and providing remedies for breach. Proper execution reduces disputes about ownership, supports trade secret protection, and helps enforce non-disclosure and assignment terms in court or arbitration under ESIGN (15 U.S.C. §7001) or UETA.

Why a properly drafted Legal CIIAA Document matters

Who typically completes and signs a Legal CIIAA Document

Confirm signer authority and signatory titles upfront; mis-signed assignments or missing authority can jeopardize ownership transfers.

  • In-house counsel or outside counsel preparing and reviewing terms before circulation.
  • Hiring managers or HR for employment-related assignment and confidentiality clauses.
  • Founders, contractors, or vendors signing to transfer IP rights and accept confidentiality obligations.

Who can sign and typical signatory roles

Corporate Officer

An authorized officer (CEO, President, VP) signs on behalf of a corporation when corporate authority is recorded in board minutes or corporate resolutions; include printed name and title to evidence authority and avoid signature disputes.

Authorized Agent

A named agent or authorized representative may sign under delegated authority; ensure the agent’s power is documented in a corporate resolution, power of attorney, or similar writing to demonstrate binding authority.

Core sections to include in a professional Legal CIIAA Document

A professional Legal CIIAA Document groups clauses so each party’s obligations and rights are clear. Include defined terms, assignment language, confidentiality scope, exceptions, term and termination, and remedies and indemnities to avoid ambiguity.

Parties and Recitals

Identify full legal names, entity types, and roles; recitals summarize the transaction context and support interpretation.

Definition of Confidential Information

Specify what is confidential, formats covered, and exclusions such as public knowledge or independently developed information.

Assignment of Inventions

State present assignment of inventions and work product arising from the engagement, including future inventions where legal.

Use and Disclosure Restrictions

Limit permitted uses, set required safeguards, and specify permitted disclosures (e.g., counsel, affiliates, court orders).

Term and Survival

Define effective and expiration dates, and state which obligations survive termination and for how long.

Governing Law and Remedies

Specify governing state law and remedies available for breach, including injunctive relief and fee-shifting if agreed.

Security and compliance elements to protect CIIAA records

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
Certifications: SOC 2 Type II; ISO 27001
Privacy Frameworks: GDPR compliance; CCPA controls
Regulated-Use Support: HIPAA support with BAA; 21 CFR Part 11 capabilities
Accessibility: WCAG 2.0 Level AA
Audit Trail: Detailed timestamps, IP, and action logs

Step-by-step: completing a Legal CIIAA Document

Follow these steps to prepare, review, and execute a legally defensible CIIAA document; confirm identity and signer authority before finalization.

  • 01
    Prepare the draft: Populate parties, definitions, and assignment clauses accurately.
  • 02
    Verify signers: Confirm signer authority and legal names before distribution.
  • 03
    Select execution method: Choose paper, RON, or eSignature consistent with law and parties’ consent.
  • 04
    Record and retain: Store fully executed copies and audit records for the required retention period.

Configuring an online signing workflow for a Legal CIIAA Document

Set up a digital workflow to control signer order, authentication, reminders, and retention so the executed document and audit log are preserved.

Field Configuration
Signing Order Sequential | Signers sign in specified sequence
Authentication Email link or SMS code | Stronger options require KBA or 2FA
Reminders & Expiry Automatic reminders | Set expiration after N days
Retention Settings Automatic archival | Save PDF plus audit trail

Where to send or file the executed Legal CIIAA Document

Decide distribution targets for executed copies to maintain compliance and allow enforcement; retain originals and share certified copies where required.

  • Internal Legal: Upload final executed copy to corporate legal repository.
  • HR or Personnel File: Place employment-related CIIAAs in employee personnel records.
  • Counterparty: Provide signed PDF and execution certificate to the other party.
  • Registrar or Agent: File with corporate records or IP counsel when necessary.

Digital signing, file formats, and integration considerations

Ensure the platform preserves a tamper-evident PDF plus a detailed audit trail to support later enforcement or regulatory review.

  • File Formats: PDF, DOCX, and PDF/A supported
  • Integrations: Salesforce, NetSuite, Microsoft 365
  • Authentication Options: Email, SMS code, KBA, SSO

Timing and date-related rules to track for a Legal CIIAA Document

Important dates affect enforceability, tax reporting, and retention; confirm effective dates, signature dates, and any filing deadlines that may attach to related filings.

Effective Date Entry:

Enter MM/DD/YYYY on the signature page to fix rights and obligations.

Signature Date vs Effective Date:

Differentiate signature date from effective date when retroactive terms are used.

Tax Reporting Triggers:

Provide correct issuer and payee details when payments trigger 1099 reporting deadlines.

I-9 Retention:

Retain I-9s three years after hire or one year after termination per 8 CFR §274a.2

Document Storage:

Preserve executed copies per retention schedule and regulatory needs.

Common mistakes to avoid when preparing a Legal CIIAA Document

  • Using informal party names instead of legal entity names, which can create ambiguity about who is bound.
  • Failing to identify confidential information with sufficient specificity, leaving scope disputes to courts.
  • Omitting signer capacity or authority, causing difficulty proving assignor had power to transfer rights.
  • Relying on an unsigned exhibit or missing dates, creating gaps in the effective transfer of rights.

Key risks and legal consequences of errors

1099 Penalties: $60–$330 per form (IRC §6721)
I-9 Violations: $281–$2,789 per violation (DHS guidance)
Intentional Disregard: $660+ per form, no cap (IRC §6721)
Breach Remedies: Injunctions and damages
Assignment Failure: Ownership disputes and litigation risk
Notarization Errors: Potential invalidation in certain states

Typical eSignature vendor comparison for executing Legal CIIAA Documents

Compare starting price, trial options, bulk send capability, audit trail availability, HIPAA compliance, and envelope or usage caps across vendors; signNow is listed first per comparison conventions.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by offer Varies by offer Varies by offer Varies by offer
Bulk Send Yes (Business Premium+) Yes Yes Yes Limited
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

Frequently asked questions about executing and managing a Legal CIIAA Document

Answers to six common questions about enforceability, eSigning, notarization, corrections, retention, and signer authority.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users